Big Profits on Promising New Opiate Addiction Treatment: 1/9
Markets started off in a slight downtrend today but recovered near the time of this writing to modest gains. The market still seems to be pausing to take stock of value opportunities after last week’s bull run.
As investors search for value upside, Chinese and other emerging market stocks have put up especially strong performances over the last several weeks, even as blockchain remains red hot. Today, we get a Top Performer emerging from the only sector consistently managing to match blockchain punch for punch in 2017: pharmaceutical development.
This morning, PTIE announced positive frontline results from its new late-stage drug development effort, REMOXY.
Delivered nasally, REMOXY is designed to offer relief to patients addicted to opiates. The active compound in REMOXY is time-released and considered less addicting than the “immediate release” oxycodone.
Opiate drug addiction continues to drive a high profile public health crisis in the United States, so any potentially efficacious treatment has real value. All study subjects tested with REMOXY reported lower rates of a “drug like high” from REMOXY and fewer expressed interest in trying the drug again. Furthermore, these patients were exposed to a lower absolute quantity of opiates than under alternative treatment approaches.
Investors were eager to get in on this potential treatment, piling into the stock after the announcement. The buying frenzy drove the stock to gains over 150% at the time of this writing.
Diverse Plays, Great Profits: All in a single news day.
Keep checking our blog for daily updates on lucrative new-based stock plays, analyst actions, and more!
We analyze news events ranging from clinical trials in the pharmaceutical industry to routine earnings releases to major geopolitical shakeups.
Or, if you’re ready to move beyond the blog and experience the power of hedge-fund caliber news analysis in a package that’s accessible to small investors, click here to sign up for a free training today. You’ll see how easy to use our platform really is—and how many profitable trades it can unlock
A powerful news analytics platform like News Quantified not only makes it easy to track the news, but to quickly compare news events with key financial information. We make it simple to find strong, diverse plays in any market environment.
How are you using the news to earn market-beating profits? How would you use the news if you had access to a real-time platform like News Quantified? Let us know in the comments below.